Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Introduction and Overview of the Intersection Betweeen Opioid Use Disorder and Infectious Diseases (19 mins)

Source: Navigating the Nexus of Addiction, HCV Infection, and HIV Infection
Watch an overview of the activity, review the syndemic nature of opioid use disorder and infectious disease, particularly HCV and HIV infection, and find out how legislative changes have enabled integration of infectious disease and opioid use disorder care in the United States.
Sandra Springer, MD
Program Director
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Released: February 6, 2020 Expiration: No longer available for credit

This program is divided into several short segments which you can step through using the Video Chapters widget.
PreviousNext

Related Content

Expert commentary by Dr Jürgen K. Rockstroh on screening for and identifying NASH in the setting of HIV, from Clinical Care Options (CCO)

Jürgen K. Rockstroh, MD Released: January 7, 2022

From Clinical Care Options (CCO) and Dr. Jurgen K. Rockstroh and Dr. Giada Sebastiani: the risk factors of NAFLD or NASH in patients with HIV

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 7, 2021 Expired: December 6, 2022

Clinical Care Options (CCO) expert commentary by Giada Sebastiani, MD, on the importance of looking for NAFLD/ NASH in patients with HIV

Giada Sebastiani, MD Released: September 29, 2021

Downloadable PDF resource from CCO on HCV and HIV screening essentials and HIV PrEP basics for addiction medicine specialists

Andrew Seaman, MD Released: October 2, 2020

Video Chapters

Intersection of OUD and ID
Benefits of Integrated Care
OUD Screening and Evaluation
Medication for OUD
Additional Considerations
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
American Society of Addiction Medicine
Educational grant provided by:
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings